Business
Tcm Biotech International Corp - Receives FDA Breakthrough Device Designation For Catchimera Mrd Platform For Hcc
Tcm Biotech International Corp - Receives FDA Breakthrough Device Designation For Catchimera Mrd Platform For Hcc
About this update from Tcm Biotech International Corp.
Tcm Biotech International Corp TWSE:4169:TCM BIOTECH INTERNATIONAL CORP - RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR CATCHIMERA MRD PLATFORM FOR HCC
View stock analysis, news, and events for Tcm Biotech International Corp.